key: cord-0979547-lulrfceb
authors: Wan, Cheng; Zhang, Chun
title: Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
date: 2021-01-16
journal: J Mol Cell Biol
DOI: 10.1093/jmcb/mjab006
sha: b2ec3bca007dff4447274deedb0c562a47ed8d67
doc_id: 979547
cord_uid: lulrfceb

nan

infective SARS-CoV-2 in kidney has been verified providing a definite evidence of renal tropism and direct invasion of SARS-CoV-2 (Braun et al., 2020) . Ascertaining the mechanism of SARS-CoV-2 entry will pave the way for preventing the infection and even tackling this epidemic.

The first step for viral invasion is the binding between SARS-CoV-2 spike protein and host cell receptors. Angiotensin-converting enzyme 2 (ACE2) is the first well-confirmed receptor for SARS-CoV-2 (Shang et al., 2020) . Receptor-binding domain (RBD) in spike protein directly binds to ACE2, thus promoting the virus-cell fusion and subsequent entry. CD147 is verified as another receptor for SARS-CoV-2 mediating viral entry by endocytosis . The redistribution of CD147 in tubular epithelial cells from basolateral pattern to circumferential pattern likely facilitates the putative invasion of SARS-CoV-2 from the lumen (Su et al., 2020) .

Neuropilin-1 highly expressed in the respiratory and olfactory epithelium is also an additional host cell receptor for SARS-CoV-2, and blocking the interaction between neuropilin-1 and viral spike protein reduces SARS-CoV-2 entry (Daly et al., 2020) . Besides the above, Yang et al. (2021) recently proposed kidney injury molecule-1 (KIM-1) as a new host factor.

KIM-1 is well-known as a sensitive biomarker of AKI and tubular injury in other kidney diseases. It is not detectable in normal kidney, but markedly upregulated in proximal tubular cells upon injury. In addition, KIM-1 is a double-edged sword in the process of kidney healing and injury.

On the one hand, it functions as a scavenger receptor facilitating the clearance of apoptotic and necrotic cells in tubular lumen and participates in the regeneration of injured tubules (Ichimura et al., 2008) . On the other hand, chronic KIM-1 expression contributes to tubulointerstitial fibrosis and inflammation (Humphreys et al., 2013) . Moreover, KIM-1 is emerging as a critical entry factor for several enveloped viruses, such as Ebola virus and Dengue virus, through direct interaction between phosphatidylserine (PtdSer) binding residues within extracellular immunoglobulin variable (IgV)-like domain and PtdSer on the viral envelope, promoting the subsequent virus internalization (Moller-Tank et al., 2014) .

SARS-CoV-2 belongs to enveloped viruses as well. In a recent study by Yang et al. (2021) , the role of KIM-1 in SARS-CoV-2 infection has been investigated. It is proposed that KIM-1 is not only a biomarker for SARS-CoV-2-associated AKI, but also a novel receptor that binds to SARS-CoV-2 RBD via IgV domain. Similar attachment has been revealed in SARS-CoV and MERS-CoV, confirming the role of KIM-1 in coronavirus invasion. It has been suggested that ACE2 and KIM-1 co-mediate the viral invasion leading to acute tubular injury, and the subsequent upregulation of KIM-1 further promotes SARS-CoV-2 entry, thus forming a vicious cycle in the kidney. However, how KIM-1 facilitates SARS-CoV-2 internalization after binding remains to be further explored.

Another remarkable finding by Yang et al. (2021) is the designed KIM-1-derived antagonist peptide covering the two SARS-CoV-2-contacting motifs (motif 1: Leu54, Phe55, Gln58; motif 2:

Trp112, Phe113) with three glycine as the flexible linker. The peptide successfully blocks the attachment between KIM-1 and SARS-CoV-2, which may help new drug discovery for SARS-CoV-2 infection (Yang et al., 2021) .

In summary, Yang et al. (2021) reveals a novel virus entry route for SARS-CoV-2, KIM-1, which also acts as a biomarker for SARS-CoV-2-associated AKI. The finding of new host cell factors may provide promising targets for developing specific and effective interventions against COVID-19.

SARS-CoV-2 renal tropism associates with acute kidney injury

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Acute kidney injury in critically ill patients with COVID-19

Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis

Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells

Characterizing functional domains for TIM-mediated enveloped virus entry

Structural basis of receptor recognition by SARS-CoV-2

Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Kidney injury molecule-1 is a potential receptor for SARS-CoV-2